Pompe disease is a rare genetic disorder that affects muscles and body functions over time. Long term treatment focuses on managing symptoms, preserving mobility, supporting breathing, and improving quality of life. This article explores current treatment approaches, including enzyme replacement therapy, supportive care, ongoing monitoring, and emerging research that may influence future disease management strategies.
Pompe disease is a rare inherited condition caused by a deficiency of an enzyme called acid alpha glucosidase. This enzyme helps break down glycogen in the body's cells. When the enzyme is lacking, glycogen accumulates and damages muscles, including those involved in movement and breathing. Because Pompe disease is a lifelong condition, long term treatment plans aim to slow disease progression, maintain function, and support overall health.